Patent · US Active

Osteoprotegerin in neuroprotection

US9670288B2 · kind B2 · utility

0Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2014
Grant dateJun 6, 2017
Priority date—
Expiry dateMar 18, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating neurodegeneration, e.g., sensorineural hearing loss, or a demyelinating disease, using bisphosphonates, ERK kinase inhibitors, and osteoprotegerin (OPG) proteins or nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.